Cochrane Evaluation of (Semi-) Automated Review (CESAR) Methods: Protocol for an adaptive platform study within reviews
Gartlehner, G.; Banda, S.; Callaghan, M.; Chase, J.-A.; Dobrescu, A.; Eisele-Metzger, A.; Flemyng, E.; Gardner, S.; Griebler, U.; Helfer, B.; Jemiolo, P.; Macura, B.; Minx, J. C.; Noel-Storr, A.; Rajabzadeh Tahmasebi, N.; Sharifan, A.; Meerpohl, J.; Thomas, J.
Show abstract
BackgroundArtificial intelligence (AI) has the potential to improve the efficiency of evidence synthesis and reduce human error. However, robust methods for evaluating rapidly evolving AI tools within the practical workflows of evidence synthesis remain underdeveloped. This protocol describes a study design for assessing the effectiveness, efficiency, and usability of AI tools in comparison to traditional human-only workflows in the context of Cochrane systematic reviews. MethodsMembers of the Cochrane Evaluation of (Semi-) Automated Review (CESAR) Methods Project developed an adaptive platform study-within-a-review (SWAR) design, modeled after clinical platform trials. This design employs a master protocol to concurrently evaluate multiple AI tools (interventions) against a standard human-only process (control) across three key review tasks: title and abstract screening, full-text screening, and data extraction. The adaptive framework allows for the addition or removal of AI tools based on interim performance analyses without necessitating a restart of the study. Performance will be assessed using metrics such as accuracy (sensitivity, specificity, precision), efficiency (time on task), response stability, impact of errors, and usability, in alignment with Responsible use of AI in evidence SynthEsis (RAISE) principles. ResultsThe study will generate comparative data about the performance and usability of specific AI tools employed in a semi- or fully automated manner relative to standard human effort. The protocol provides a flexible framework for the assessment of AI tools in evidence synthesis, addressing the limitations of static, one-time evaluations. DiscussionThis study protocol presents a novel methodological approach to addressing the challenges of evaluating AI tools for evidence syntheses. By validating entire workflows rather than individual technologies, the findings will establish an evidence base for determining the viability of integrating AI into evidence-synthesis workflows. The adaptive design of this study is flexible and can be adopted by other investigators, ensuring that the evaluation framework remains relevant as new tools emerge.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions 98%
- Agreeability testing of AMSTAR-PF, a tool for quality appraisal of systematic reviews of prognostic factor studies 96%
- GPT for RCTs?: Using AI to measure adherence to reporting guidelines 95%
Similar papers in this journal
- Evaluation of the sensitivity, accuracy and currency of the Cochrane COVID-19 Study Register for supporting rapid evidence synthesis production 96%
- Exploring the potential of Claude 2 for risk of bias assessment: Using a large language model to assess randomized controlled trials with RoB 2 96%
- Development of the Individual Participant Data (IPD) Integrity Tool for assessing the integrity of randomised trials using individual participant data 96%
Similar papers in this journal
Similar papers in this journal
- Does pre-notification increase questionnaire response rates: a nested randomised control trial 95%
- Does advance contact with research participants increase response to questionnaires: A Systematic Review and meta-Analysis 94%
- Quantitative bias analysis for mismeasured variables in health research: a review of software tools 93%
Similar papers in this journal
- Large language models for conducting systematic reviews: on the rise, but not yet ready for use – a scoping review 95%
- Updating the PRISMA reporting guideline for network meta-analysis: a scoping review 95%
- The use of the Registered Reports format for publication of randomized clinical trials: a cross-sectional study 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.